such as dopamine (DA), noradrenaline (NA), and serotonin (5-HT) play a pivotal role in several physiological and psychological functions. Several reports have suggested that monoaminergic system disruption is related to psychiatric disorders including schizophrenia, depression, autism, and attention-deficit hyperactivity disorder (Froehlich et al., 2010; Nakamura et al., 2010; Paclt et al., 2009) .
We previously demonstrated that nano-sized TiO 2 , administered to pregnant mice, was transferred to the offspring and affected the reproductive and central nervous system of male offspring . Because a fetus is highly vulnerable to environmental stimuli, chemical exposure in the fetal period generally disrupts its development (Kawashiro et al., 2008; Needham and Sexton, 2000) . Although these aspects suggest that the detrimental health effects of the NPs would be more profound in fetuses than in adults, the potential toxicity of prenatal exposure of NPs is less investigated. We recently reported that prenatal exposure to TiO 2 NPs affects gene expression related to the development and function of the central nervous systems including the monoaminergic system (Shimizu, et al. 2009 ). Because ZnO NPs are also widely used in cosmetics, there is a concern with the health effects of prenatal ZnO NP exposure on offspring. Previous studies suggest that ZnO NPs induce cytotoxicity and oxidative stress in primary mouse embryonic fibroblast (Yang et al., 2009) and developmental disorder in Zebrafish (Zhu et al., 2008) ; however its health effects on offspring exposed to ZnO NPs during the fetal period are largely unknown. In the present study, we investigated the effects of prenatal exposure to ZnO NPs on the monoaminergic systems. We comprehensively examined the levels of monoamines and their metabolites in 9 regions of the brain in mice using high performance liquid chromatography (HPLC).
MATERIALS AND METHODS

ZnO particles
Mz-300 NPs, ZnO with a primary diameter of 30-40 nm, were kindly provided by Tayca Co. (Osaka, Japan). ZnO NPs were dispersed in saline containing 0.05% Tween-80, and the sample suspension was sonicated for 90 min in a bath-type sonicator immediately before administration. To minimize the heat production, the bath was filled with enough volume of water. A wide distribution of ZnO powder of different diameters was confirmed by field emission-type scanning electron microscopy. The size distribution of the ZnO NPs in the suspension was measured by dynamic light scattering using an FPAR-1000 (Otsuka Electronics Co., Ltd., Osaka, Japan). Size distribution of ZnO NPs was assessed with the CONTIN algorithm to obtain the diameter distribution of polydispersed particles from dynamic light scattering data.
Animals
Pregnant ICR mice (8-11-week-old) at gestation day (GD) 1 were purchased from SLC Co. (Shizuoka, Japan). ZnO NPs were suspended at 0.5 mg/ml, and 0.2 ml was administrated subcutaneously to the pregnant ICR mice at GD 5, 8, 11, 14, and 17 (100 μg/mouse/day: total 500 μg/mouse). Administered ZnO NPs was same as the mass dose in the previous study about the effects of prenatal TiO 2 NP exposure on dopaminergic system (Takahashi et al., 2010) . Control mice were treated with saline containing 0.05% Tween-80. In each group, pups were weaned on postnatal day 21. They were housed under controlled conditions with a 12 hr light/ 12 hr dark cycle and ad libitum access to food and water. All experiments were handled in accordance with the institutional and national guidelines for the care and use of laboratory animals. All efforts were made to minimize the number of animals used and their suffering.
HPLC analysis of neurotransmitters
Brains were removed from 6-week-old anesthetized male pups (n = 8/group). Only male mice were analyzed in this study because the neurotransmitter variations were seen during different stages of the estrous cycle in female mice (Dazzi et al., 2007; Xiao and Becker, 1994) . Serial coronal sections of the brain (2 mm thick) were obtained using a Rodent brain slicer (MUROMACHI KIKAI, Tokyo, Japan) and dissected to 9 regions: prefrontal cortex, neostriatum (caudate-putamen), nucleus accumbens, hippocampus, amygdala, hypothalamus, midbrain, brainstem, and cerebellum. The dissected regions were immediately frozen in liquid nitrogen and stored at -80°C until use.
Frozen brain tissue was homogenized in ice-cold perchloric acid containing 100 mM EDTA (2Na) and 100 ng isoproterenol as an internal standard. The homogenates were centrifuged at 20,000 × g for 15 min at 0°C. Supernatants were transferred to new tubes and the pellets were stored for protein assay. The pH of the supernatant was adjusted to 3.0 with 1 M sodium acetate, and stored at -80°C until use. For HPLC analysis, 10 μl of the pH-adjusted supernatant were injected into an HPLC system with electrochemical detection (EICOM Co., Kyoto, Japan). Monoamines were separated by a C18 reverse-phase column (EICOMPAK SC-5ODS, EICOM) with a mobile phase containing sodium acetate and citric acid. The mobile phase was prepared as follows: 0.1 M sodium acetate was mixed with 0.1 M citric acid in a 10:9 ratio, and was adjusted to pH 3.5 (0.1 M sodium acetatecitric acid buffer), mixed with methanol in a ratio of 85:15 and then supplemented with sodium 1-octanesulfonate (100 mg/l), EDTA (2Na) (5 mg/ml). DA, 3, 4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 3-methoxytyramine (3-MT), NA, normetanephrin (NM), 3-methoxy-4-hydrophenyl (MHPG), 5-HT, and 5-hydroxyindole-3-acetic acid (5-HIAA) were analyzed.
Protein assay
Pellets were resuspended in 100 mM Tris-HCl (pH 10.4) and protein concentration was determined using Advanced Protein Assay Reagent (Cytoskeleton Inc., Denver, CO, USA). Measurements were performed according to the manufacturer's protocol.
Statistical analysis
The data were expressed as mean ± S.E.M. Differences between groups were examined for statistical significance using a Mann-Whitney U-test. P < 0.05 indicated statistical significance.
RESULTS
Size distribution and agglomeration state in suspension of ZnO NPs
A scanning electron microscope image of ZnO NPs dispersed in saline containing 0.05% Tween-80 is shown in Fig. 1A . ZnO NPs were slightly aggregated. The size distribution of secondary ZnO NPs in the suspension, analyzed by dynamic light scattering, ranged from 80 to 700 nm with 190 nm being the mode value (Fig. 1B) .
Monoamine levels in 9 regions of the brain in ZnO NP-exposed mice
We first examined the effect of prenatal exposure to ZnO NPs on the levels of DA and its metabolites (DOPAC, HVA, and 3-MT; Fig. 2, Supplementary Table 1 ). DOPAC and HVA were significantly increased in the prefrontal cortex of ZnO NP-exposed mice (DOPAC, + 49.1%; HVA, +28.4%; Fig. 2 ). DA and HVA were significantly increased in the hippocampus. Moreover, DA levels were decreased in the cerebellum. 3-MT level was not altered significantly in any of the regions of the brain examined in the present study. Next, we calculated the metabolic turnover of DA ((DOPAC+HVA+3MT)/DA), and found that it was significantly increased in the prefrontal cortex, neostriatum, nucleus accumbens, and amygdala in the ZnO NP-exposed group.
5-HT level was decreased in the hypothalamus, and 5-HIAA level was increased in the prefrontal cortex and hippocampus in ZnO NP-exposed mice (Fig. 3,  Supplementary Table 2 ). The metabolic turnover of 5-HT (5-HIAA/5-HT) was increased in 8 regions of ZnO NPexposed mice (Fig. 3, Supplementary Table 2) .
We then measured the levels of NA and its metabolites (NM, MHPG; Supplementary Fig. 1 , Supplementary Table 3 ). NM level was increased in the hippocampus of ZnO NP-exposed mice. In addition, MHPG level was decreased in the hypothalamus, and cerebellum. NA level was not altered significantly in any of the regions of the brain examined in the present study. The metabolic turnover of the NA was decreased in the hypothalamus, and amygdala of the ZnO NP-exposed mice.
DISCUSSION
Developmental disorders of the brain caused by genetic and environmental factors are of great significance to psychiatric health. Previous studies indicated an association between chemical exposure in the environment and monoaminergic neurotransmitter regulation (Matsuda et al., 2010; Xia et al., 2011; Sirivelu et al., 2006) . The monoaminergic system plays an important role in mental health, and its dysregulation leads to psychiatric dysfunction, such as behavioral depression, anxiety disorder, and Parkinsonism (Weiss et al., 1981; Elsworth and Roth, 1997; Morilak and Frazer, 2004) . It is noteworthy that prenatal stress can cause profound and long-lasting deficits in brain functions (Chung et al., 2005; Son et al., 2006) . Maternally-stressed male mice have been shown to indicate altered dopaminergic responses (Son et al., 2007) . Furthermore, Narita et al. (2002) , showed that fetal thalidomide or valproic acid exposure resulted in increased monoamine concentration in the brain, and induced an autism-like phenotype in rats.
In the present study, we comprehensively analyzed the amount of monoamines and their metabolites using HPLC in adult offspring mice. In the ZnO NP-exposed group, metabolic turnover of DA and 5-HT was significantly increased in the prefrontal cortex, neostriatum, nucleus accumbens, and amygdala. In the prefrontal cortex in particular, the levels of DA metabolites (DOPAC and HVA) and a 5-HT metabolite (5-HIAA) were significantly increased. 5-HT neurons of the raphe nucleus are projected to prefrontal cortex and neostriatum, and the activity of 5-HT and DA neuron systems are mutually regulated (Assié et al., 2005) . Oades (2008) reported that the metabolic turnover of DA and 5-HT are simultaneously increased in attention-deficit hyperactivity disorder patients. These reports reveal the importance of the balance of activity and metabolism of DA and 5-HT in the monoaminergic system of the brain. Combined with these reports, prenatal exposure to ZnO NPs induced monoaminergic neurotransmitter disruption, in particular in the imbalance of DA and 5-HT levels, which potentially affects the mental and behavioral health of offspring. On the other hand, increased serotonin turnover in the prefrontal cortex and increased dopamine turnover in hippocampus, which were also observed in this study, were associated with interferon-α-induced depression (De La Garza and Asnis, 2003) . Moreover, Barton et al. (2008) reported that brain serotonin turnover was elevated in patients with depression. These reports suggest the prenatally ZnO-exposed mice represent depression-like behavior. Further behavioral tests should be performed to solve the effects of prenatal ZnO NP exposure on the mental and behavioral health of offspring.
Synthesized neurotransmitters are stored in synaptic vesicles and then released from vesicles when action potential reaches the synaptic terminal. Released neurotransmitters are immediately inactivated by reuptake or metabolism. Although we measured the activity of monoamine oxygenase (a key enzyme in the metabolism of DA, NA, and 5-HT) in the prefrontal cortex and nucleus accumbens, we did not detect any significant alteration ( Supplementary Fig 2) . Because the increase of metabolic turnover depends on the increase of the amount of monoamines present in synaptic cleft, further examination regarding this point may reveal the mechanism of ZnO NP-mediated increase of metabolic turnover of monoamines.
Although the mechanism of monoaminergic system disruption due to prenatal ZnO NP exposure is unclear, one possible mechanism is that prenatal exposure to ZnO NPs induced reactive oxygen species (ROS), which may influence the function of the monoaminergic system in offspring. Previous studies have reported that exposure to NPs, including ZnO NPs, produces ROS, and induces oxidative stress (Long et al., 2006; Xia et al., 2008) . ROS-induced oxidative stress would cause functional impairment of the monoaminergic system via dysregulation of monoaminergic neurotransmitter metabolism. Monoaminergic systems may also be disrupted by Zn 2+ ,which dissolves from ZnO NPs. Cho et al. (2011) showed that the toxicity of dissolved Zn 2+ from ZnO NPs is much greater than a similar mass of ZnO NPs. Previous reports indicated that Zn 2+ suppresses the function of the GABA A receptor through allosteric mechanism (Hosie et al., 2003) . Taken together with the report which showed GABA A receptors regulate dopamine release in the prefrontal cortex (Santiago et al., 1993) , an increase in Zn 2+ caused by prenatal ZnO NP exposure may affect the release and metabolism of DA through suppression of the GABA A receptor function. Additionally, the monoamine transporters may be disrupted by dissolved Zn 2+ from ZnO NPs. Previous report indicated that Zn 2+ plays a role in the monoamine transporters associated with monoamine metabolism (Scholze et al., 2002) . Further investigations of the interaction of prenatal ZnO NP exposure induced-monoamine disruption with ROS and Zn 2+ will clarify these issues.
In conclusion, the present data indicated that prenatal exposure to ZnO NPs disrupted the levels of monoamine neurotransmitters of the brain and suggested that ZnO NPs could have potential toxicity with regard to mental health. Taken together with the report that ZnO NPs show higher developmental toxicity than other metal oxide NPs including TiO 2 and Al 2 O 3 (Zhu et al., 2008) , the assumption would follow that avoidance of toxicity induced by ZnO NPs is an important for the issue in mental health. The toxicity of NPs is related to its characteristics of deposition and translocation to the tissues . We previously reported that subcutaneously injected TiO 2 NPs were translocated to the brain of offspring . ZnO NPs may also be transferred to the brain of offspring and affect the monoaminergic systems. Recent studies indicated that the interaction of NP surface with the proteins is important for the distribution of NPs in the body. Several reports showed that surface coating of NPs changed its accumulation and translocation to the tissues and its toxicity Choi et al., 2010) . In order for ZnO NPs to be used safely, further studies are needed to clarify the molecular mechanisms of monoamine neurotransmitter disruption and to determine how the toxicity of ZnO NPs might be reduced.
